Sagcilo, Maria Remie M.
HRN: 28-12-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2025
CEFAZOLIN 1GM (VIAL)
12/17/2025
12/24/2025
IV
1
Q8
Giant Cell Tumor
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes